Showing results (1331-1340 of 1,354) with videos related to

Sort By:
Pageof 136
Diabetologia|October 12, 2012
The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study, R A Scott, C Langenberg, et al.
Diabetes Care|February 11, 2016
Association of Multiple Biomarkers of Iron Metabolism and Type 2 Diabetes: The EPIC-InterAct StudyClara Podmore, Karina Meidtner, Matthias B Schulze, et al.
European Journal of Clinical Nutrition|June 7, 2012
The association of education with long-term weight change in the EPIC-PANACEA cohortS Rohrmann, A Steinbrecher, J Linseisen, et al.
The Lancet. Diabetes & Endocrinology|August 10, 2014
Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort studyNita G Forouhi, Albert Koulman, Stephen J Sharp, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): a validation of existing modelsAndre Pascal Kengne, Joline W J Beulens, Linda M Peelen, et al.
Plos Medicine|October 16, 2020
The association between circulating 25-hydroxyvitamin D metabolites and type 2 diabetes in European populations: A meta-analysis and Mendelian randomisation analysisJu-Sheng Zheng, Jian'an Luan, Eleni Sofianopoulou, et al.
Plos Medicine|May 22, 2014
Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort studyClaudia Langenberg, Stephen J Sharp, Paul W Franks, et al.
JAMA|May 13, 2024
Prognostic Value of Cardiovascular Biomarkers in the PopulationJohannes Tobias Neumann, Raphael Twerenbold, Jessica Weimann, et al.
Diabetes|June 21, 2014
Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesityRobert A Scott, Tove Fall, Dorota Pasko, et al.
International Journal of Cancer|December 10, 2013
Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-results from the EPIC cohort studyVincent K Dik, H B As Bueno-de-Mesquita, Martijn G H Van Oijen, et al.
Pageof 136